İki Kompartımanlı Açık Model: IV Bolus Uygulaması

The two-compartment model divides the body into central and peripheral compartments to represent drug distribution. The central compartment includes the blood and highly perfused tissues where the drug is administered intravenously. The peripheral compartment represents less perfused tissues. Drug reversibly transfers between these compartments at rates determined by transfer constants k12 and k21, allowing the model to capture the biphasic nature of drug disposition.

Plasma concentration exhibits a bi-exponential decline because two distinct disposition processes occur sequentially: distribution and elimination. Initially, the drug rapidly distributes from the central compartment to peripheral tissues, causing a steep concentration drop. Subsequently, the elimination phase dominates as the drug is cleared from the central compartment. This biphasic profile reflects the combined effects of inter-compartmental transfer and elimination rate constants.

The method of residuals resolves the biexponential distribution curve into individual exponents by plotting plasma drug concentration versus time on a semilog scale. The slope of the residual line obtained from this plot yields the transfer constants k12 and k21, which describe the reversible drug transfer rate between compartments. This graphical technique separates the rapid distribution phase from the slower elimination phase for accurate parameter estimation.

From the elimination rate constant β for the entire body, the elimination half-life can be directly calculated. Additionally, other essential pharmacokinetic parameters such as volume of distribution and clearance can be determined using suitable equations. These parameters collectively describe how the drug behaves within the body, including its distribution extent and the rate at which it is removed from circulation.

The transfer constants k12 and k21 are first-order rate constants that denote the reversible drug transfer rate between central and peripheral compartments. k12 represents the rate of drug movement from the central to peripheral compartment, while k21 represents movement in the opposite direction. These constants, along with the elimination rate constant k10, determine the hybrid first-order constants that govern the rapid distribution and slow elimination phases.

The distribution phase occurs immediately after IV bolus administration when drug rapidly transfers from the central compartment to peripheral tissues, causing a steep plasma concentration decline. The elimination phase follows, characterized by slower concentration decrease as the drug is cleared from the central compartment. The transition between these phases reflects the changing dominance of inter-compartmental transfer versus elimination processes.

The two-compartment model more accurately represents drug behavior by accounting for both distribution to peripheral tissues and elimination from the body. Unlike simpler models, it captures the biphasic plasma concentration profile observed clinically, reflecting the physiological reality that drugs distribute unevenly across body tissues. This complexity allows for better prediction of drug concentrations at different times and more accurate dosing recommendations.